(Q42540037)

2 November 2017

title

1,5-Bis(4-amidinophenoxy)pentane (pentamidine) is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 binding sites (English)

1 reference

2 November 2017

0 references

1 reference

Wood DH

1

1 reference

2 November 2017

Hall JE

series ordinal

2

1 reference

2 November 2017

Rose BG

series ordinal

3

1 reference

2 November 2017

Tidwell RR

series ordinal

4

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

European Journal of Pharmacology

2 November 2017

published in

1 reference

2 November 2017

volume

353

1 reference

2 November 2017

issue

1

1 reference

2 November 2017

page(s)

97-103

1 reference

Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Pentamidine-induced derangements of glucose homeostasis. Determinant roles of renal failure and drug accumulation. A study of 128 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Isolation and partial purification of a clonidine-displacing endogenous brain substance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

7 January 2021

Imidazoline receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Structure and DNA binding activity of analogs of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

I1 agents: a new approach to the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Agmatine: an endogenous clonidine-displacing substance in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Characterization of the imidazoline binding site involved in regulation of insulin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Pentamidine and hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Why imidazoline receptor modulator in the treatment of hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

7 January 2021

Studies in Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900386-0

10.1016/S0014-2999(98)00386-0

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference